MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL

Clinical trials for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL explained in plain language.

Never miss a new study

Get alerted when new MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL trials appear

Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Antibiotic shows promise in controlling rare eye cancer

Disease control Completed

This study tested whether a long course of the antibiotic doxycycline could control a rare type of eye lymphoma (OAMZL) linked to a bacterial infection. 44 newly diagnosed patients received the antibiotic, and doctors monitored for infection return, retreating if needed. The goal…

Matched conditions: MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL

Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL

Get alerted when new MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL trials appear

Antibiotic shows promise in controlling rare eye cancer